• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Oncology - Market size and forecast 2020-2025
o Cardiovascular - Market size and forecast 2020-2025
o Anti-infectives - Market size and forecast 2020-2025
o Others - Market size and forecast 2020-2025
o Market opportunity by Product
• Market Segmentation by Source
o Invertebrate
o Vertebrate
o Others
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o Asia - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o BeyondSpring Inc.
o Bristol-Myers Squibb Co.
o Eisai Co. Ltd.
o GlaxoSmithKline Plc
o Jazz Pharmaceuticals Plc
o Pfizer Inc.
o PharmaMar SA
o F. Hoffmann-La Roche Ltd.
o Seagen Inc.
o TerSera Therapeutics LLC
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Product - Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Oncology - Market size and forecast 2020-2025 ($ million)
• 24: Oncology - Year-over-year growth 2020-2025 (%)
• 25: Cardiovascular - Market size and forecast 2020-2025 ($ million)
• 26: Cardiovascular - Year-over-year growth 2020-2025 (%)
• 27: Anti-infectives - Market size and forecast 2020-2025 ($ million)
• 28: Anti-infectives - Year-over-year growth 2020-2025 (%)
• 29: Others - Market size and forecast 2020-2025 ($ million)
• 30: Others - Year-over-year growth 2020-2025 (%)
• 31: Market opportunity by Product
• 32: Customer landscape
• 33: Market share by geography 2020-2025 (%)
• 34: Geographic comparison
• 35: North America - Market size and forecast 2020-2025 ($ million)
• 36: North America - Year-over-year growth 2020-2025 (%)
• 37: Europe - Market size and forecast 2020-2025 ($ million)
• 38: Europe - Year-over-year growth 2020-2025 (%)
• 39: Asia - Market size and forecast 2020-2025 ($ million)
• 40: Asia - Year-over-year growth 2020-2025 (%)
• 41: ROW - Market size and forecast 2020-2025 ($ million)
• 42: ROW - Year-over-year growth 2020-2025 (%)
• 43: Key leading countries
• 44: Market opportunity by geography ($ million)
• 45: Impact of drivers and challenges
• 46: Vendor landscape
• 47: Landscape disruption
• 48: Industry risks
• 49: Vendors covered
• 50: Market positioning of vendors
• 51: BeyondSpring Inc. - Overview
• 52: BeyondSpring Inc. - Product and service
• 53: BeyondSpring Inc. - Key offerings
• 54: BeyondSpring Inc. - Key customers
• 55: BeyondSpring Inc. - Segment focus
• 56: Bristol-Myers Squibb Co. - Overview
• 57: Bristol-Myers Squibb Co. - Product and service
• 58: Bristol-Myers Squibb Co. - Key offerings
• 59: Bristol-Myers Squibb Co. - Key customers
• 60: Bristol-Myers Squibb Co. - Segment focus
• 61: Eisai Co. Ltd. - Overview
• 62: Eisai Co. Ltd. - Business segments
• 63: Eisai Co. Ltd. - Key offerings
• 64: Eisai Co. Ltd. - Key customers
• 65: Eisai Co. Ltd. - Segment focus
• 66: GlaxoSmithKline Plc - Overview
• 67: GlaxoSmithKline Plc - Business segments
• 68: GlaxoSmithKline Plc - Key offerings
• 69: GlaxoSmithKline Plc - Key customers
• 70: GlaxoSmithKline Plc - Segment focus
• 71: Jazz Pharmaceuticals Plc - Overview
• 72: Jazz Pharmaceuticals Plc - Business segments
• 73: Jazz Pharmaceuticals Plc - Key offerings
• 74: Jazz Pharmaceuticals Plc - Key customers
• 75: Jazz Pharmaceuticals Plc - Segment focus
• 76: Pfizer Inc. - Overview
• 77: Pfizer Inc. - Business segments
• 78: Pfizer Inc. - Key offerings
• 79: Pfizer Inc. - Key customers
• 80: Pfizer Inc. - Segment focus
• 81: PharmaMar SA - Overview
• 82: PharmaMar SA - Business segments
• 83: PharmaMar SA - Key offerings
• 84: PharmaMar SA - Key customers
• 85: PharmaMar SA - Segment focus
• 86: F. Hoffmann-La Roche Ltd. - Overview
• 87: F. Hoffmann-La Roche Ltd. - Business segments
• 88: F. Hoffmann-La Roche Ltd. - Key offerings
• 89: F. Hoffmann-La Roche Ltd. - Key customers
• 90: F. Hoffmann-La Roche Ltd. - Segment focus
• 91: Seagen Inc. - Overview
• 92: Seagen Inc. - Business segments
• 93: Seagen Inc. - Key offerings
• 94: Seagen Inc. - Key customers
• 95: Seagen Inc. - Segment focus
• 96: TerSera Therapeutics LLC - Overview
• 97: TerSera Therapeutics LLC - Product and service
• 98: TerSera Therapeutics LLC - Key offerings
• 99: TerSera Therapeutics LLC - Key customers
• 100: TerSera Therapeutics LLC - Segment focus
• 101: Currency conversion rates for US$
• 102: Research Methodology
• 103: Validation techniques employed for market sizing
• 104: Information sources
• 105: List of abbreviations

Companies Mentioned
. BeyondSpring Inc.
. Bristol-Myers Squibb Co.
. Eisai Co. Ltd.
. GlaxoSmithKline Plc
. Jazz Pharmaceuticals Plc
. Pfizer Inc.
. PharmaMar SA
. F. Hoffmann-La Roche Ltd.
. Seagen Inc.
. TerSera Therapeutics LLC